F-group (family)
2002.1.1.108 NMO
Ligands and drugs
156
Member domains
55
with ligand contacts (≤ 4 Å)
35.3% of members
47
with DrugDomain annotations
30.1% of members
46
with a DrugBank compound
29.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.108 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03247 | FMN | Flavin mononucleotide | 44 |
| DB14128 | NAD | Nadide | 3 |
| DB02338 | NDP | NADPH | 2 |
| DB08657 | TUI | 2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FMN | FLAVIN MONONUCLEOTIDE | 52 |
| SF4 | IRON/SULFUR CLUSTER | 11 |
| CAmetal | CALCIUM ION | 8 |
| NAmetal | SODIUM ION | 6 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 3 |
| NIE | nitroethane | 3 |
| 66S | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate | 2 |
| A1ECY | methyl 3-[[2-[(2,4-dichlorophenyl)amino]pyridin-3-yl]sulfonylamino]benzoate | 2 |
| N1P | 1-nitropropane | 2 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 2 |
| PN7 | N~3~-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide | 2 |
| TUI | 2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID | 2 |
| 33O | 3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontane-1,38-diol | 1 |
| A1CIO | N-{[4-(4-bromophenyl)-1H-imidazol-2-yl]methyl}-N'-[6-(trifluoromethyl)-1,3-benzothiazol-2-yl]urea | 1 |
| A1ELE | 3-methoxy-N-[5-[(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]benzamide | 1 |
| A1ELF | N-[5-[(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]naphthalene-2-carboxamide | 1 |
| A1ELG | N-[5-[(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-3-(trifluoromethyloxy)benzamide | 1 |
| A1ELH | 3-bromanyl-N-[5-[[3-(dimethylamino)phenyl]sulfamoyl]-1,3,4-thiadiazol-2-yl]benzamide | 1 |
| A1EMD | N-[5-[[3-(dimethylamino)phenyl]sulfamoyl]-1,3,4-thiadiazol-2-yl]naphthalene-2-carboxamide | 1 |
| CL | CHLORIDE ION | 1 |